Anna A Lushnikova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anna A Lushnikova has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Anastasia V Onyan
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
2 shared publications - Irina N. Mikhaylova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
2 shared publications - Ksenia Kozhikhova
NRC Institute of Immunology FMBA Moscow Russia
2 shared publications - Sergey M. Andreev
National Research Center – Institute of Immunology Federal Medical-Biological Agency of Russia
2 shared publications - Alexandr V Kostarev1 shared publication
- Anastasiia V. Shatilova
National Research Center – Institute of Immunology of the Federal Medical-Biological Agency, Moscow
1 shared publication
Latest Publications
- 1 January 2022
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 43 (3)
Supercationic peptide dendrimers as vectors for nucleic acids delivery to mammalian cells
Суперкатионные пептидные дендримеры как векторы для доставки нуклеиновых кислот в клетки млекопитающих
- 1 January 2022
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 43 (3)
Supercationic peptide dendrimers as vectors for nucleic acids delivery to mammalian cells
Суперкатионные пептидные дендримеры как векторы для доставки нуклеиновых кислот в клетки млекопитающих
- Open Access
- 29 June 2021
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 20 (3) , 98-106
ANALYSIS OF CANCER-TESTIS ANTIGENS AS POTENTIAL MARKERS FOR DISSEMINATION OF PRIMARY HUMAN SKIN MELANOMA
Purpose of the study: to analyze characteristics of cancer-testis antigens (Ctas) as potential biomarkers for dissemination of primary human skin melanoma (sm).Material and Methods. Recent publications from Pubmed, scopus and elibrary databases were analyzed for the available appropriate literature review. In total, 176 papers reported the description of Ctas and encoding genes and their potential for prognosis of primary sm dissemination. The authors included 52 of them in the given review.Results. Two sections of the paper comprise clinically significant characteristics of Ctas and their genes, including overexpression, which is selective for the heterogeneous tumor cell populations and mediated by humoral and/or cellular immune reactions; the association of tumor process and activation of Cta genes by demethylation of promotor sites, which is correlated with tumor progression; and the conditions required for effective immunotherapy involving Ctas and/or their genes.Conclusion. At present, there are no standards or clinical recommendations for the Cta-based prognosis of the early dissemination of primary skin melanoma. Therefore, it is important to study and analyze the Cta and encoding gene characteristics that reveal the connection between primary sm progression and tumor genesis including the role of circulating tumor cells (ctc), similar to stem cells, which have epithelial-mesenchymal transition (emt) phenotype, for clinical diagnostics of early sm dissemination. As a result of the study, the following Ctas could be considered as significant biomarkers of the early sm dissemination: mage-a1, mage-a4 and ny-eso-1, which expression correlates with the clinical pathological description of the disease progression, as well as with the relapse-free period and overall survival of the patients; magea3, which expression correlates with spag5 activation and Cd8+ t-cell abundance; ssx, a marker for stem cell migration including identification of the cells with emt and/or ctcs; and prame, signaling marker for dissemination of the uveal melanoma.
- 29 June 2021
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 20 (3) , 98-106
Open AccessANALYSIS OF CANCER-TESTIS ANTIGENS AS POTENTIAL MARKERS FOR DISSEMINATION OF PRIMARY HUMAN SKIN MELANOMA
Purpose of the study: to analyze characteristics of cancer-testis antigens (Ctas) as potential biomarkers for dissemination of primary human skin melanoma (sm).Material and Methods. Recent publications from Pubmed, scopus and elibrary databases were analyzed for the available appropriate literature review. In total, 176 papers reported the description of Ctas and encoding genes and their potential for prognosis of primary sm dissemination. The authors included 52 of them in the given review.Results. Two sections of the paper comprise clinically significant characteristics of Ctas and their genes, including overexpression, which is selective for the heterogeneous tumor cell populations and mediated by humoral and/or cellular immune reactions; the association of tumor process and activation of Cta genes by demethylation of promotor sites, which is correlated with tumor progression; and the conditions required for effective immunotherapy involving Ctas and/or their genes.Conclusion. At present, there are no standards or clinical recommendations for the Cta-based prognosis of the early dissemination of primary skin melanoma. Therefore, it is important to study and analyze the Cta and encoding gene characteristics that reveal the connection between primary sm progression and tumor genesis including the role of circulating tumor cells (ctc), similar to stem cells, which have epithelial-mesenchymal transition (emt) phenotype, for clinical diagnostics of early sm dissemination. As a result of the study, the following Ctas could be considered as significant biomarkers of the early sm dissemination: mage-a1, mage-a4 and ny-eso-1, which expression correlates with the clinical pathological description of the disease progression, as well as with the relapse-free period and overall survival of the patients; magea3, which expression correlates with spag5 activation and Cd8+ t-cell abundance; ssx, a marker for stem cell migration including identification of the cells with emt and/or ctcs; and prame, signaling marker for dissemination of the uveal melanoma.
- Open Access
- 30 October 2019
- Published by MedCrave Group Kft. in Journal of Cancer Prevention & Current Research
- Vol. 10 (5) , 62-65
Overcoming of doxorubicin resistance in breast cancer cells by cationic peptides
Background: Acquired resistance to various drugs is an obstacle to anticancer therapy. Doxorubicin (Dox) is the first-line chemo-drug for therapy of various malignant tumors but it fails when treatment of multi-drug resistant tumors. One of the main factors of Dox-resistance is overexpression of drug resistance genes, particularly, P-glycoprotein – Pgp. Earlier we’ve revealed a high selective apoptosis of tumor cells, induced by some cationic peptides (CPs) in vitro through inactivation their cell targets – chaperone proteins nucleolin/NCL and nucleophosmin/NPM. This paper describes effect of CPs on breast cancer (BC) cell lines HBL 100 and doxorubicin-resistant cell line HBL-100/Dox. Objective: Is to examine the viability of BC and Dox-resistant BC cells after incubation with some CPs. Results: Some Arg/Lys-enriched cationic peptides under study induce cell death by nucleolar stress mechanisms both in HBL 100 BC cell line and HBL 100/ID 120 one. So, this CPs is perspective agents for inducing apoptosis of BC cells and overcoming Dox resistance.
- 30 October 2019
- Published by MedCrave Group Kft. in Journal of Cancer Prevention & Current Research
- Vol. 10 (5) , 62-65
Open AccessOvercoming of doxorubicin resistance in breast cancer cells by cationic peptides
Background: Acquired resistance to various drugs is an obstacle to anticancer therapy. Doxorubicin (Dox) is the first-line chemo-drug for therapy of various malignant tumors but it fails when treatment of multi-drug resistant tumors. One of the main factors of Dox-resistance is overexpression of drug resistance genes, particularly, P-glycoprotein – Pgp. Earlier we’ve revealed a high selective apoptosis of tumor cells, induced by some cationic peptides (CPs) in vitro through inactivation their cell targets – chaperone proteins nucleolin/NCL and nucleophosmin/NPM. This paper describes effect of CPs on breast cancer (BC) cell lines HBL 100 and doxorubicin-resistant cell line HBL-100/Dox. Objective: Is to examine the viability of BC and Dox-resistant BC cells after incubation with some CPs. Results: Some Arg/Lys-enriched cationic peptides under study induce cell death by nucleolar stress mechanisms both in HBL 100 BC cell line and HBL 100/ID 120 one. So, this CPs is perspective agents for inducing apoptosis of BC cells and overcoming Dox resistance.
- Open Access
- 28 February 2019
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 18 (1) , 86-94
Phenotypic plasticity of metastatic melanoma
Introduction. Metastatic melanoma is characterized by clinical and morphological heterogeneity and plasticity. Rare cases of metastatic melanoma are known, that have no visual expression of melanocytic markers. Contradictory histology of such melanomas requires a differential diagnosis from morphologically similar non- melanocytic tumors, sarcoma or lymphoma. objective is to describe the extraordinary cases of metastatic melanomas with low expression of differentiation markers. material and methods. 15 melanoma cases with unusual clinical and morphological characteristics were included in the study. These tumors were examined by pathologist and cytologist, by immunohistochemical and FISH analyses, mutations in BRAF, NRAS and KIT genes were detected by PCR. results. Some primary tumors were amelanotic, therefore, they were difficult for differential tumor diagnosis. Most frequently, primary tumors were located on the back, shin or head. In 4 patients the primary focuses were not detected. Metastatic lesions were as large nodular tumors in soft tissues of the back or lower limb. Most tumors belong to mixed or spindle-cell histological types. Spindle-shaped cells were also revealed by cytological analysis. BRAF gene mutations were identified by genetic analysis in 27 % of tumors, NRAS and KIT gene mutations were not detected. In 4 cases FISH analysis was performed to detect EWSR1 gene rearrangements, but it did not confirm the diagnosis of sarcoma. conclusion. The results indicate the presence of a heterogeneous group of melanoma cases, which have a number of morphological and molecular features that bring them closer to sarcomas.
- 28 February 2019
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 18 (1) , 86-94
Open AccessPhenotypic plasticity of metastatic melanoma
Introduction. Metastatic melanoma is characterized by clinical and morphological heterogeneity and plasticity. Rare cases of metastatic melanoma are known, that have no visual expression of melanocytic markers. Contradictory histology of such melanomas requires a differential diagnosis from morphologically similar non- melanocytic tumors, sarcoma or lymphoma. objective is to describe the extraordinary cases of metastatic melanomas with low expression of differentiation markers. material and methods. 15 melanoma cases with unusual clinical and morphological characteristics were included in the study. These tumors were examined by pathologist and cytologist, by immunohistochemical and FISH analyses, mutations in BRAF, NRAS and KIT genes were detected by PCR. results. Some primary tumors were amelanotic, therefore, they were difficult for differential tumor diagnosis. Most frequently, primary tumors were located on the back, shin or head. In 4 patients the primary focuses were not detected. Metastatic lesions were as large nodular tumors in soft tissues of the back or lower limb. Most tumors belong to mixed or spindle-cell histological types. Spindle-shaped cells were also revealed by cytological analysis. BRAF gene mutations were identified by genetic analysis in 27 % of tumors, NRAS and KIT gene mutations were not detected. In 4 cases FISH analysis was performed to detect EWSR1 gene rearrangements, but it did not confirm the diagnosis of sarcoma. conclusion. The results indicate the presence of a heterogeneous group of melanoma cases, which have a number of morphological and molecular features that bring them closer to sarcomas.
- Open Access
- 15 September 2018
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 5 (3) , 59-64
Cytotoxic cationic peptides as а ligands for receptor nucleolin
Background. Chaperone proteins nucleolin (NCL, or C23) and nucleophosmin (NPM, or B23) regulate key cell functions. The most tumors are characterized by over-expression of these proteins, especially in cell nuclei and on the сell surface, as NCL. Differential expression of NCL/NPM in tumor and normal cells is the basis of selective cytotoxicity of cationic peptides – expected ligands for these proteins. Objective. Analysis of the interactions between nucleolin and some peptides with high nonspecific toxicity for tumor cells. Materials and methods. The interaction of 4 previously characterized cationic peptides with nucleolin dimer was analyzed by pair molecular docking using Maestro 11 program. Results and conclusion. It is shown that these peptides can associate with receptor nucleolin molecules, forming energy-stable complexes. In the active centre of NCL molecule were found, at least, 7 positions of amino acids, which bind to the tested peptides at a high frequency (43–100 %). This indicates the conservative structure of dimer NCL, its stable binding to peptide ligands and the possibility of design the optimal structure of cationic peptides that induce tumor cell death due to competing binding to the target proteins.
- 15 September 2018
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 5 (3) , 59-64
Open AccessCytotoxic cationic peptides as а ligands for receptor nucleolin
Background. Chaperone proteins nucleolin (NCL, or C23) and nucleophosmin (NPM, or B23) regulate key cell functions. The most tumors are characterized by over-expression of these proteins, especially in cell nuclei and on the сell surface, as NCL. Differential expression of NCL/NPM in tumor and normal cells is the basis of selective cytotoxicity of cationic peptides – expected ligands for these proteins. Objective. Analysis of the interactions between nucleolin and some peptides with high nonspecific toxicity for tumor cells. Materials and methods. The interaction of 4 previously characterized cationic peptides with nucleolin dimer was analyzed by pair molecular docking using Maestro 11 program. Results and conclusion. It is shown that these peptides can associate with receptor nucleolin molecules, forming energy-stable complexes. In the active centre of NCL molecule were found, at least, 7 positions of amino acids, which bind to the tested peptides at a high frequency (43–100 %). This indicates the conservative structure of dimer NCL, its stable binding to peptide ligands and the possibility of design the optimal structure of cationic peptides that induce tumor cell death due to competing binding to the target proteins.